title: NICE rules out NHS prescription of fingolimod for multiple sclerosis.
authors.forename: Deborah
authors.initials: D
authors.lastname: Cohen
mesh_terms: D003362:Cost-Benefit Analysis; D000068876:Fingolimod Hydrochloride; D017048:Health Care Costs; D006801:Humans; D007166:Immunosuppressive Agents / Q000191:economics / Q000627:therapeutic use*; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000188:drug therapy*; D009313:National Health Programs / Q000331:legislation & jurisprudence*; D055553:Prescription Drugs / Q000191:economics* / Q000627:therapeutic use; D011409:Propylene Glycols / Q000191:economics / Q000627:therapeutic use*; D013110:Sphingosine / Q000031:analogs & derivatives* / Q000191:economics / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D007166:Immunosuppressive Agents; D055553:Prescription Drugs; D011409:Propylene Glycols; D000068876:Fingolimod Hydrochloride; D013110:Sphingosine